JP2015512936A5 - - Google Patents

Download PDF

Info

Publication number
JP2015512936A5
JP2015512936A5 JP2015505730A JP2015505730A JP2015512936A5 JP 2015512936 A5 JP2015512936 A5 JP 2015512936A5 JP 2015505730 A JP2015505730 A JP 2015505730A JP 2015505730 A JP2015505730 A JP 2015505730A JP 2015512936 A5 JP2015512936 A5 JP 2015512936A5
Authority
JP
Japan
Prior art keywords
fucosyl
sialyl lactose
prebiotic composition
oligosaccharide
sialyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015505730A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015512936A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/030764 external-priority patent/WO2013154725A1/en
Publication of JP2015512936A publication Critical patent/JP2015512936A/ja
Publication of JP2015512936A5 publication Critical patent/JP2015512936A5/ja
Pending legal-status Critical Current

Links

JP2015505730A 2012-04-13 2013-03-13 プレバイオティクス組成物およびその使用方法 Pending JP2015512936A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261623868P 2012-04-13 2012-04-13
US61/623,868 2012-04-13
PCT/US2013/030764 WO2013154725A1 (en) 2012-04-13 2013-03-13 Prebiotic compositions and methods of use

Publications (2)

Publication Number Publication Date
JP2015512936A JP2015512936A (ja) 2015-04-30
JP2015512936A5 true JP2015512936A5 (https=) 2016-05-12

Family

ID=49328018

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015505730A Pending JP2015512936A (ja) 2012-04-13 2013-03-13 プレバイオティクス組成物およびその使用方法

Country Status (6)

Country Link
US (1) US20150265661A1 (https=)
EP (1) EP2836218A4 (https=)
JP (1) JP2015512936A (https=)
CN (1) CN104507483A (https=)
MX (1) MX2014012362A (https=)
WO (1) WO2013154725A1 (https=)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2451462B1 (en) 2009-07-06 2017-09-06 Children's Hospital Medical Center Inhibiting inflammation with milk oligosaccharides
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
WO2014036182A2 (en) 2012-08-29 2014-03-06 California Institute Of Technology Diagnosis and treatment of autism spectrum disorder
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
EP2885977A1 (en) * 2013-12-19 2015-06-24 Agriculture and Food Development Authority (TEAGASC) An oligosaccharide-enriched composition having immune-modulatory and anti-adhesion properties
US20150305385A1 (en) * 2014-04-25 2015-10-29 Mead Johnson Nutrition Company Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics
WO2016063262A1 (en) 2014-10-24 2016-04-28 Glycom A/S MIXTURES OF HMOs
US11040049B2 (en) 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
PL3212198T3 (pl) * 2014-10-29 2021-08-23 Glycom A/S Syntetyczna kompozycja i sposób promowania gojenia się błony śluzowej
EP3212197A4 (en) * 2014-10-29 2018-07-11 Glycom A/S Synthetic composition and method for treating irritable bowel syndrome
US11040050B2 (en) 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
WO2016069801A1 (en) * 2014-10-30 2016-05-06 California Institute Of Technology Compositions and methods comprising bacteria for improving behavior in neurodecelopmental disorders
EA201790811A1 (ru) 2014-10-30 2017-11-30 Калифорния Инститьют Оф Текнолоджи Содержащие бактерии композиции и способы для улучшения видов поведения при нарушениях неврологического развития
US10987368B2 (en) 2014-12-08 2021-04-27 Glycom A/S Synthetic composition for preventing or treating CVD
US10881674B2 (en) 2014-12-08 2021-01-05 Glycom A/S Synthetic composition for treating metabolic disorders
CN107106584A (zh) 2014-12-08 2017-08-29 格礼卡姆股份公司 用于治疗代谢障碍的合成组合物
US10835544B2 (en) 2014-12-08 2020-11-17 Glycom A/S Synthetic composition for regulating satiety
WO2016102950A1 (en) * 2014-12-23 2016-06-30 4D Pharma Research Limited Immune modulation
SG11201704814SA (en) 2014-12-23 2017-07-28 4D Pharma Res Ltd Pirin polypeptide and immune modulation
AU2018205072B2 (en) * 2014-12-23 2020-05-21 Cj Bioscience, Inc. Immune modulation
WO2016176484A1 (en) 2015-04-28 2016-11-03 Children's Hospital Medical Center Use of oligosaccharide compositions to enhance weight gain
WO2016203221A1 (en) 2015-06-15 2016-12-22 4D Pharma Research Limited Compositions comprising bacterial strains
ME03511B (me) 2015-06-15 2020-04-20 4D Pharma Res Ltd Kompozicije koje sadrže bakterijske sojeve
HRP20191949T1 (hr) 2015-06-15 2020-01-24 4D Pharma Research Limited Blautia stercosis i wexlerae za upotrebu u liječenju upalnih i autoimunih bolesti
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
EP3368047B1 (en) 2015-10-28 2023-04-26 Glycom A/S Synthetic composition and method for modulating emotion and mood disorders
US10835545B2 (en) 2015-10-28 2020-11-17 Glycom A/S Synthetic composition and method for modulating brain function and behaviour
CN108348536B (zh) * 2015-11-17 2021-09-24 格礼卡姆股份公司 治疗抗生素相关性并发症的合成组合物
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
HK1254843B (zh) 2015-11-20 2020-04-17 希杰生物科技株式会社 包含细菌菌株的组合物
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
EP3389668A4 (en) 2015-12-15 2019-08-21 Glycom A/S MIXTURE OF HMOS
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
SG10201913557TA (en) 2016-03-04 2020-02-27 4D Pharma Plc Compositions comprising bacterial blautia strains for treating visceral hypersensitivity
WO2017160711A1 (en) 2016-03-14 2017-09-21 Holobiome, Inc. Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system
DK3452050T3 (da) * 2016-05-05 2023-02-20 Glycom As Composition comprising hmos for the treatment of noninfectious diarrhoea
EP3458073B1 (en) 2016-05-19 2023-10-25 Glycom A/S Use of human milk oligosaccharides for treating migraine in patients with inflammatory bowel syndrome
EP3478093A4 (en) 2016-07-01 2020-03-04 Evolve Biosystems, Inc. METHOD FOR ELEVATING THE MATURATION OF THE MAMMAL IMMUNE SYSTEM
TWI802545B (zh) 2016-07-13 2023-05-21 英商4D製藥有限公司 包含細菌菌株之組合物
SG10202100843TA (en) 2016-07-28 2021-03-30 Fonterra Cooperative Group Ltd Dairy product and process
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
WO2018112194A1 (en) 2016-12-15 2018-06-21 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for modulating growth of a genetically modified gut bacterial cell
KR102019364B1 (ko) * 2017-02-27 2019-09-06 한국생명공학연구원 시아릴락토오스를 유효성분으로 포함하는 항균용 조성물
AU2018250337B2 (en) * 2017-04-07 2024-02-15 Children's Hospital Medical Center Treatment of inflammatory bowel diseases with 2'-fucosyllactose compounds
ES2877726T3 (es) 2017-05-22 2021-11-17 4D Pharma Res Ltd Composiciones que comprenden cepas bacterianas
EP3630942B1 (en) 2017-05-24 2022-11-30 4D Pharma Research Limited Compositions comprising bacterial strain
ES2841902T3 (es) 2017-06-14 2021-07-12 4D Pharma Res Ltd Composiciones que comprenden cepas bacterianas
TWI812624B (zh) 2017-06-14 2023-08-21 南韓商希杰生物科技股份有限公司 包含細菌品系之組成物
PL3600363T3 (pl) 2017-06-14 2021-06-14 4D Pharma Research Limited Kompozycje zawierające szczepy bakteryjne
WO2019071021A2 (en) * 2017-10-04 2019-04-11 The Regents Of The University Of California IMMUNOMODULATORY OLIGOSACCHARIDES
BR112020010843A2 (pt) * 2017-11-30 2020-11-10 Glycom A/S oligossacarídeos do leite humano e composições sintéticas desses para modulação da microbiota
US11304966B2 (en) 2017-12-22 2022-04-19 Glycom A/S Composition comprising HMOs for preventing or reducing nociception
CA3093384A1 (en) * 2018-03-08 2019-09-12 Plexus Worldwide Llc Compositions and methods for skin renewal
CN108935698A (zh) * 2018-09-11 2018-12-07 内蒙古伊利实业集团股份有限公司 一种预防小儿腹泻疾病的营养组合物及应用
BE1027078A9 (nl) * 2019-02-25 2020-09-28 Nutribam Bvba Samenstelling, voedingssupplement en werkwijze voor het ondersteunen en/of verbeteren van de darmgezondheid
WO2020174386A1 (en) 2019-02-25 2020-09-03 Nutribam Bvba Composition, food supplement and method for supporting and/or improving intestinal health
CN110257299B (zh) * 2019-07-11 2022-06-10 锦州医科大学 一种阴沟肠杆菌在促进反刍动物生长的应用
CN112869167A (zh) * 2019-11-29 2021-06-01 内蒙古伊利实业集团股份有限公司 副干酪乳杆菌k56提升肠道细菌感染抗性和肠道免疫力的应用
JP7474596B2 (ja) * 2020-01-20 2024-04-25 森永乳業株式会社 新規ビフィドバクテリウム属細菌、および当該細菌を含む組成物、並びに当該細菌の増殖促進用の組成物
CN111363671B (zh) * 2020-02-26 2023-07-21 天津医科大学 一种肠道厌氧微生物培养瓶及其制备方法
WO2021197492A1 (zh) * 2020-04-03 2021-10-07 内蒙古伊利实业集团股份有限公司 可提升生物体对金黄色葡萄球菌感染的抵御能力的母乳低聚糖
CN112075637B (zh) * 2020-04-27 2023-05-23 合生元(广州)健康产品有限公司 一种减少肠道气体产生的组合物
CN112841543A (zh) * 2021-01-28 2021-05-28 重庆周师兄餐饮文化有限公司 一种麻辣脆的加工方法
US20240306690A1 (en) 2021-01-29 2024-09-19 Societe Des Produits Nestle S.A. Mixture of hmos and bifidobacteria
CN112890200B (zh) * 2021-03-08 2021-11-12 合生元(广州)健康产品有限公司 用于促进低体重婴幼儿生长追赶的一种营养组合物
WO2022223430A1 (en) * 2021-04-19 2022-10-27 Dsm Ip Assets B.V. A composition of enzymes and human milk oligosaccharides
MX2024000324A (es) * 2021-07-09 2024-01-25 Nestle Sa Usos de un microorganismo de bifidobacterium longum de transicion.
CN113796545B (zh) * 2021-09-13 2022-09-13 合生元(广州)健康产品有限公司 调节肠道免疫功能的母乳低聚糖组合物及其应用
KR102411242B1 (ko) * 2021-10-18 2022-06-22 큐티스바이오 주식회사 클렙시엘라 아에로제네스의 피부 상태 개선 용도
DK202200588A1 (en) 2022-06-20 2024-02-23 Dsm Ip Assets Bv Mixture of fucosylated HMOs
CN115920013A (zh) * 2022-11-15 2023-04-07 合生元(广州)健康产品有限公司 乳源成分在降低单增李斯特菌引起的感染风险中的应用
CN116042486B (zh) * 2023-02-22 2024-11-08 高邮市人民医院 一种用于治疗动脉粥样硬化的复合菌制剂

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6630452B2 (en) * 2000-02-17 2003-10-07 Wyeth Nutritional formulation containing prebiotic substances
US20060127546A1 (en) * 2004-08-27 2006-06-15 Purac Biochem B.V. Use of glycine and/or glycine derivatives as antibacterial agent against gram negative bacterial pathogens in foods and/or drinks
EP2451462B1 (en) * 2009-07-06 2017-09-06 Children's Hospital Medical Center Inhibiting inflammation with milk oligosaccharides
FI20096400A0 (fi) * 2009-12-28 2009-12-28 Suomen Punainen Risti Veripalv Veriryhmästatuksen käyttö I
WO2011136647A1 (en) * 2010-04-27 2011-11-03 N.V. Nutricia Use of 6'-sialyl lactose in infant and toddler nutrition
EP2465508A1 (en) * 2010-11-23 2012-06-20 Nestec S.A. Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases
MY197622A (en) * 2010-12-31 2023-06-28 Abbott Lab Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
CA2825697A1 (en) * 2011-02-10 2012-08-16 Nestec S.A. Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk

Similar Documents

Publication Publication Date Title
JP2015512936A5 (https=)
JP2015164123A5 (https=)
CN302072736S (zh) 水龙头(hda1715l)
CN302064961S (zh) 水龙头(hda1815l)
CN302082441S (zh) 水龙头(hda1818xh)
CN302061246S (zh) 门夹(2745)
CN302533123S (zh) 全封闭冰箱门锁(二)
CN302155520S (zh) 水龙头(面盆-0008)
CN302494800S (zh) 拉手(6)
CN302357283S (zh) 炕几(816266)
CN302570606S (zh) 洋间扇(s35115r、s35116rt)
CN302487805S (zh) 拉手(5)
CN302134782S (zh) 水龙头(面盆-0007)
CN302533098S (zh) 拉手(1)
CN302533124S (zh) 全封闭冰箱门锁(一)
CN302527088S (zh) 冰箱(164)
CN302221899S (zh) 盥洗台(y-02)
CN302520114S (zh) Pvc消音地板(02)
CN302250786S (zh) 三门酒柜(88870)
CN302552769S (zh) 花洒(th3190)
CN302439651S (zh) 锁内面板(04款)
CN302494849S (zh) 门锁前锁体(圆形/椭圆形)
CN302176827S (zh) 淋浴龙头(0025)
CN302356963S (zh) 脚踏(816267a)
CN302378080S (zh) 脚踏(816075)